Compounds > naringenin

naringenin and Cancer of Liver

naringenin has been researched along with Cancer of Liver in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's5 (50.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Lai, J; Li, Y; Su, J; Wu, Q; Zhang, M; Zhu, B1
Abdulaal, WH; ALbukhari, A; Bawazeer, NA; Choudary, H; Middleton, B; Moselhy, SS; Zamzami, MA; Zeyadi, M1
Cao, F; Cao, P; Cheng, Y; He, Y; Jia, B; Meng, X; Wang, Y; Yang, C; Yu, D; Yu, G1
Arul, D; Subramanian, P2
Liu, CJ; Yeh, CC; Yen, HR1
Borradaile, NM; de Dreu, LE; Huff, MW1
Han, EH; Jeong, HG; Jeong, TC; Kim, JY; Lee, ES; Shin, DW; Woo, ER1
Fukuda, S; Kojiro, M; Nakashima, O; Ookawa, K; Sakata, Y; Suto, K; Takahata, T; Tamura, Y; Tanaka, M; Tateishi, T; Yano, H1
Casali, M; Chung, RT; Goldwasser, J; Nahmias, Y; van Poll, D; Wakita, T; Yarmush, ML1

Other Studies

10 other study(ies) available for naringenin and Cancer of Liver

ArticleYear
Naringenin Induces HepG2 Cell Apoptosis via ROS-Mediated JAK-2/STAT-3 Signaling Pathways.
    Molecules (Basel, Switzerland), 2023, Jun-01, Volume: 28, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Signal Transduction

2023
POSSIBLE REGULATION OF LDL-RECEPTOR BY NARINGENIN IN HEPG2 HEPATOMA CELL LINE.
    African journal of traditional, complementary, and alternative medicines : AJTCAM, 2017, Volume: 14, Issue:1

    Topics: Carcinoma, Hepatocellular; Flavanones; Gene Expression Regulation; Hep G2 Cells; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Receptors, LDL; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2

2017
Naringenin ameliorates insulin resistance by modulating endoplasmic reticulum stress in hepatitis C virus-infected liver.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 115

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Endoplasmic Reticulum Stress; Endoribonucleases; Flavanones; Gene Expression Regulation; Hepacivirus; Hepatitis C; Humans; Insulin Resistance; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Protein Serine-Threonine Kinases

2019
Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells.
    Pathology oncology research : POR, 2013, Volume: 19, Issue:4

    Topics: Analysis of Variance; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Growth Processes; Flavanones; Hep G2 Cells; Humans; Liver Neoplasms

2013
Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.
    Chemico-biological interactions, 2015, Jun-25, Volume: 235

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Movement; Flavanones; Hep G2 Cells; Humans; I-kappa B Proteins; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Neoplasm Invasiveness; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphorylation; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1

2015
Attenuation of NDEA-induced hepatocarcinogenesis by naringenin in rats.
    Cell biochemistry and function, 2013, Volume: 31, Issue:6

    Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Down-Regulation; Flavanones; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Nitrosamines; Rats; Up-Regulation

2013
Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation.
    Diabetes, 2003, Volume: 52, Issue:10

    Topics: Animals; Apolipoproteins B; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; DNA-Binding Proteins; Enzyme Activation; Fatty Acids; Flavanones; Humans; Insulin Receptor Substrate Proteins; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Receptors, LDL; Sterol Regulatory Element Binding Protein 1; Transcription Factors; Triglycerides; Tyrosine

2003
Suppression of CYP1A1 expression by naringenin in murine Hepa-1c1c7 cells.
    Archives of pharmacal research, 2004, Volume: 27, Issue:8

    Topics: Animals; Carcinoma, Hepatocellular; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavanones; Gene Expression Regulation, Enzymologic; Liver Neoplasms; Mice

2004
Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines.
    Basic & clinical pharmacology & toxicology, 2008, Volume: 102, Issue:4

    Topics: Acridines; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flavanones; Gene Expression Regulation, Neoplastic; Glucuronosyltransferase; Humans; Inhibitory Concentration 50; Irinotecan; Liver Neoplasms; Neoplasm Proteins; RNA, Messenger; Tetrahydroisoquinolines; Transfection

2008
Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.
    Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:5

    Topics: Apolipoproteins B; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Citrus paradisi; DNA Primers; Enzyme-Linked Immunosorbent Assay; Flavanones; Gene Silencing; Hepacivirus; Humans; Liver Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Viral Core Proteins

2008